XJPX
7459
Market cap3.82bUSD
Oct 09, Last price
2,953.50JPY
1D
0.15%
1Q
12.04%
Jan 2017
60.26%
Name
Medipal Holdings Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Medipal Holdings Corporation, a Tokyo-based Japanese company founded in 1898, primarily operates as a wholesaler of prescription pharmaceuticals throughout Japan. Beyond its core drug distribution, the company also sources and supplies a comprehensive range of healthcare-related products, including medical equipment, materials, and clinical diagnostic reagents, used from the earliest pre-symptomatic stages through treatment. Its services extend to offering post-marketing surveillance (PMS) to pharmaceutical manufacturers and investing in the development of orphan drugs. Medipal's extensive wholesale activities also encompass a diverse array of other goods, such as cosmetics, daily necessities, over-the-counter medications, and animal health products for companion animals. Furthermore, it provides raw materials for food processing in agriculture, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. In addition to its product distribution, Medipal delivers a suite of specialized services: conducting contract-based epidemiological and clinical studies, developing computerized medical supply and master product databases for healthcare facilities, and offering solutions for health insurance claims review, medical coding, outsourcing, and remote educational programs. Its operations further include managing life and non-life insurance agencies, providing cleaning services, overseeing distribution center logistics, offering commissioned delivery and staffing solutions, and developing and managing services for Class A health dispensing pharmacies. Medipal serves a broad client base, including hospitals, clinics, dispensing pharmacies, various retail outlets like drugstores, home centers, convenience stores, supermarkets, and discount stores, as well as animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was previously known as Mediceo Paltac Holdings Co., Ltd. before adopting its current name in October 2009.
Key people
Shuichi Watanabe
President, Chief Executive Officer, Representative Director · since 2022
Hiroshi Yarimizu
Senior Managing Executive Officer, Deputy Chief Director of Administration, Director of Finance and Accounting · since 2024
Shinjiro Watanabe
President of Subsidiary, Director · since 2021
Senior Managing Director, Chief Director of Business Development · since 2022
Managing Director, Chief Director of Administration · since 2018
Tetsuya Shoji
Senior Executive Officer, Chief Director of System · since 2025
Masahiro Fujimaki
Executive Officer · since 2025
Tadashi Hagiwara
Executive Officer, Deputy Chief Director of Administration · since 2025
Yoshitaka Ichiyanagi
Executive Officer, President of Subsidiary · since 2021
Takeshi Kumakura
Executive Officer, Chief Director of Data Insight, Director of Presus Business Promotion, President of Subsidiary · since 2025
Yasuhiko Sugimori
Executive Officer, Deputy Chief Director of Main Business Development Unit, Director of Business Development · since 2024
Ryo Ukita
Executive Officer, Director in charge of Business Investment Unit in Main Business Development Unit · since 2024
Yasuhiro Chofuku
Vice President, Chairman of Subsidiary, Representative Director · since 2025
Kuniaki Imagawa
President of Subsidiary, Director · since 2022
Hidemitsu Wakita
Director · since 2025
President of Subsidiary, Director · since 2023
Independent Director · since 2017
Hiroshi Iwamoto
Independent Director · since 2021
Mitsuko Kagami
Independent Director · since 2014
Kuniko Shoji
Independent Director · since 2018
Headquarters & legal address
京橋三丁目1番1号
東京都 中央区 104-8461
JP
東京都 中央区 104-8461
JP
Address
3-1-1, Kyobashi
Chuo-ku Tokyo 104-8461
JP
Chuo-ku Tokyo 104-8461
JP
Other language
MEDIPAL HOLDINGS CORPORATION
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||